Skip to main content
NCBI home page
Gut logoLink to Gut
. 1995 Oct;37(4):530–535. doi: 10.1136/gut.37.4.530

Colitis and colonic mucosal barrier dysfunction.

K R Gardiner 1, N H Anderson 1, B J Rowlands 1, A Barbul 1
PMCID: PMC1382906  PMID: 7489941

Abstract

Trauma, infection, neoplasia, and inflammation can all disrupt the intact intestinal mucosal barrier to intraluminal bacteria and bacterial antigens. This study investigated the relation between colonic inflammation and colonic mucosal barrier function in three experimental models of colitis. There were significantly increased systemic endotoxin concentrations in rats with acetic acid (7.5 (1.7-119.5) pg/ml), ethanol (13.7 (0-111.2) pg/ml), and hapten induced (14.4 (5-31.1) pg/ml) colitis compared with saline controls (3.3 (0-13.7) pg/ml). Data expressed as median (range). There were significant correlations between the systemic endotoxin concentration and both the severity of colitis and of illness in acetic acid induced colitis. A significant increase in colonic permeability to 14C-polyethylene glycol was shown in rats with acetic acid (3.42 (1.36-5.63)%) and hapten induced colitis (2.86 (1.03-8.10)%) compared with saline controls (1.20 (0.67-1.36)%). Data expressed as median (range) of percentage of the intracolonic bolus excreted in urine. There was a significant positive correlation between the severity of colitis and % colonic permeability to 14C-polyethylene glycol. This and other studies provide evidence that mucosal barrier dysfunction is a feature of colitis irrespective of aetiology or species. Such barrier dysfunction may be responsible for the systemic inflammatory response and complications seen in patients with inflammatory bowel disease.

Full text

PDF
530

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrose N. S., Johnson M., Burdon D. W., Keighley M. R. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery. Br J Surg. 1984 Aug;71(8):623–625. doi: 10.1002/bjs.1800710821. [DOI] [PubMed] [Google Scholar]
  2. Aoki K. A study of endotoxemia in ulcerative colitis and Crohn's disease. I. Clinical study. Acta Med Okayama. 1978 Jun;32(2):147–158. [PubMed] [Google Scholar]
  3. Aoki K. A study of endotoxemia in ulcerative colitis and Crohn's disease. II. Experimental study. Acta Med Okayama. 1978 Jul;32(3):207–216. [PubMed] [Google Scholar]
  4. Berg R. D., Garlington A. W. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun. 1979 Feb;23(2):403–411. doi: 10.1128/iai.23.2.403-411.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boughton-Smith N. K., Wallace J. L., Morris G. P., Whittle B. J. The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat. Br J Pharmacol. 1988 May;94(1):65–72. doi: 10.1111/j.1476-5381.1988.tb11500.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brock-Utne J. G., Gaffin S. L. Endotoxins and anti-endotoxins (their relevance to the anaesthetist and the intensive care specialist). Anaesth Intensive Care. 1989 Feb;17(1):49–55. doi: 10.1177/0310057X8901700111. [DOI] [PubMed] [Google Scholar]
  7. Casellas F., Aguadé S., Soriano B., Accarino A., Molero J., Guarner L. Intestinal permeability to 99mTc-diethylenetriaminopentaacetic acid in inflammatory bowel disease. Am J Gastroenterol. 1986 Sep;81(9):767–770. [PubMed] [Google Scholar]
  8. Chadwick V. S., Gaginella T. S., Carlson G. L., Debongnie J. C., Phillips S. F., Hofmann A. F. Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J Lab Clin Med. 1979 Nov;94(5):661–674. [PubMed] [Google Scholar]
  9. Chadwick V. S., Phillips S. F., Hofmann A. F. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). I. Chemical analysis and biological properties of PEG 400. Gastroenterology. 1977 Aug;73(2):241–246. [PubMed] [Google Scholar]
  10. Colin R., Grancher T., Lemeland J. F., Hecketsweiler P., Galmiche J. P., Le Grix A., Geffroy Y. Recherche d'une endotoxinémie dans les entéro-colites inflammatoires cryptogénétiques. Gastroenterol Clin Biol. 1979 Jan;3(1):15–19. [PubMed] [Google Scholar]
  11. Cuevas P., Fine J. Demonstration of a lethal endotoxemia in experimental occlusion of the superior mesenteric artery. Surg Gynecol Obstet. 1971 Jul;133(1):81–83. [PubMed] [Google Scholar]
  12. Delahunty T., Recher L., Hollander D. Intestinal permeability changes in rodents: a possible mechanism for degraded carrageenan-induced colitis. Food Chem Toxicol. 1987 Feb;25(2):113–118. doi: 10.1016/0278-6915(87)90143-8. [DOI] [PubMed] [Google Scholar]
  13. Dickinson R. J., Varian S. A., Axon A. T., Cooke E. M. Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut. 1980 Sep;21(9):787–792. doi: 10.1136/gut.21.9.787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Eade M. N., Brooke B. N. Portal bacteraemia in cases of ulcerative colitis submitted to colectomy. Lancet. 1969 May 17;1(7603):1008–1009. doi: 10.1016/s0140-6736(69)91802-9. [DOI] [PubMed] [Google Scholar]
  15. Fordtran J. S., Rector F. C., Locklear T. W., Ewton M. F. Water and solute movement in the small intestine of patients with sprue. J Clin Invest. 1967 Mar;46(3):287–298. doi: 10.1172/JCI105531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fossard D. P., Kakkar V. V. The Limulus test in experimental and clinical endotoxaemia. Br J Surg. 1974 Oct;61(10):798–804. doi: 10.1002/bjs.1800611013. [DOI] [PubMed] [Google Scholar]
  17. Gaginella T. S., Chadwick V. S., Debongnie J. C., Lewis J. C., Phillips S. F. Perfusion of rabbit colon with ricinoleic acid: dose-related mucosal injury, fluid secretion, and increased permeability. Gastroenterology. 1977 Jul;73(1):95–101. [PubMed] [Google Scholar]
  18. Gardiner K. R., Anderson N. H., McCaigue M. D., Erwin P. J., Halliday M. I., Rowlands B. J. Adsorbents as antiendotoxin agents in experimental colitis. Gut. 1993 Jan;34(1):51–55. doi: 10.1136/gut.34.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gardiner K. R., Erwin P. J., Anderson N. H., Barr J. G., Halliday M. I., Rowlands B. J. Colonic bacteria and bacterial translocation in experimental colitis. Br J Surg. 1993 Apr;80(4):512–516. doi: 10.1002/bjs.1800800436. [DOI] [PubMed] [Google Scholar]
  20. Gardiner K. R., Halliday M. I., Barclay G. R., Milne L., Brown D., Stephens S., Maxwell R. J., Rowlands B. J. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut. 1995 Jun;36(6):897–901. doi: 10.1136/gut.36.6.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hotta T., Yoshida N., Yoshikawa T., Sugino S., Kondo M. Lipopolysaccharide-induced colitis in rabbits. Res Exp Med (Berl) 1986;186(1):61–69. doi: 10.1007/BF01851834. [DOI] [PubMed] [Google Scholar]
  22. Jenkins R. T., Goodacre R. L., Rooney P. J., Bienenstock J., Sivakumaran T., Walker W. H. Studies of intestinal permeability in inflammatory diseases using polyethylene glycol 400. Clin Biochem. 1986 Oct;19(5):298–302. doi: 10.1016/s0009-9120(86)80045-5. [DOI] [PubMed] [Google Scholar]
  23. Jenkins R. T., Jones D. B., Goodacre R. L., Collins S. M., Coates G., Hunt R. H., Bienenstock J. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am J Gastroenterol. 1987 Nov;82(11):1159–1164. [PubMed] [Google Scholar]
  24. Keighley M. R., Arabi Y., Dimock F., Burdon D. W., Allan R. N., Alexander-Williams J. Influence of inflammatory bowel disease on intestinal microflora. Gut. 1978 Dec;19(12):1099–1104. doi: 10.1136/gut.19.12.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kirsner J. B., Shorter R. G. Recent developments in nonspecific inflammatory bowel disease (second of two parts). N Engl J Med. 1982 Apr 8;306(14):837–848. doi: 10.1056/NEJM198204083061404. [DOI] [PubMed] [Google Scholar]
  26. Kiss A., Ferenci P., Graninger W., Pamperl H., Pötzi R., Meryn S. Endotoxaemia following colonoscopy. Endoscopy. 1983 Jan;15(1):24–26. doi: 10.1055/s-2007-1018600. [DOI] [PubMed] [Google Scholar]
  27. Kruis W., Schussler P., Weinzierl M., Galanos C., Eisenburg J. Circulating lipid A antibodies despite absence of systemic endotoxemia in patients with Crohn's disease. Dig Dis Sci. 1984 Jun;29(6):502–507. doi: 10.1007/BF01296269. [DOI] [PubMed] [Google Scholar]
  28. MacPherson B. R., Pfeiffer C. J. Experimental production of diffuse colitis in rats. Digestion. 1978;17(2):135–150. doi: 10.1159/000198104. [DOI] [PubMed] [Google Scholar]
  29. Magliulo E., Scevola D., Fumarola D. Limulus test in Escherichia coli enteritis. Lancet. 1975 Feb 15;1(7903):407–407. doi: 10.1016/s0140-6736(75)91337-9. [DOI] [PubMed] [Google Scholar]
  30. Mahida Y. R., Kurlac L., Gallagher A., Hawkey C. J. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut. 1991 Dec;32(12):1531–1534. doi: 10.1136/gut.32.12.1531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Matthews N., Mayberry J. F., Rhodes J., Neale L., Munro J., Wensinck F., Lawson G. H., Rowland A. C., Berkhoff G. A., Barthold S. W. Agglutinins to bacteria in Crohn's disease. Gut. 1980 May;21(5):376–380. doi: 10.1136/gut.21.5.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Morris G. P., Beck P. L., Herridge M. S., Depew W. T., Szewczuk M. R., Wallace J. L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989 Mar;96(3):795–803. [PubMed] [Google Scholar]
  33. Nolan J. P. Endotoxin, reticuloendothelial function, and liver injury. Hepatology. 1981 Sep-Oct;1(5):458–465. doi: 10.1002/hep.1840010516. [DOI] [PubMed] [Google Scholar]
  34. O'Morain C. A., Abelow A. C., Chervu L. R., Fleischner G. M., Das K. M. Chromium 51-ethylenediaminetetraacetate test: a useful test in the assessment of inflammatory bowel disease. J Lab Clin Med. 1986 Nov;108(5):430–435. [PubMed] [Google Scholar]
  35. Psaila J. V., Myers B., Jones I. R., Rhodes J. Effect of prostaglandin PGE2 on alcohol-induced ulceration in the rat colon. Digestion. 1986;35(4):224–228. doi: 10.1159/000199372. [DOI] [PubMed] [Google Scholar]
  36. Rachmilewitz D., Simon P. L., Schwartz L. W., Griswold D. E., Fondacaro J. D., Wasserman M. A. Inflammatory mediators of experimental colitis in rats. Gastroenterology. 1989 Aug;97(2):326–337. doi: 10.1016/0016-5085(89)90068-1. [DOI] [PubMed] [Google Scholar]
  37. Rask-Madsen J., Hammersgaard E. A., Knudsen E. Rectal electrolyte transport and mucosal permeability in ulcerative colitis and Crohn's disease. J Lab Clin Med. 1973 Mar;81(3):342–353. [PubMed] [Google Scholar]
  38. Seidman E. G., Hanson D. G., Walker W. A. Increased permeability to polyethylene glycol 4000 in rabbits with experimental colitis. Gastroenterology. 1986 Jan;90(1):120–126. doi: 10.1016/0016-5085(86)90083-1. [DOI] [PubMed] [Google Scholar]
  39. Shorter R. G., Huizenga K. A., Spencer R. J. A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease. Am J Dig Dis. 1972 Nov;17(11):1024–1032. doi: 10.1007/BF02239143. [DOI] [PubMed] [Google Scholar]
  40. Vilaseca J., Salas A., Guarner F., Rodríguez R., Martínez M., Malagelada J. R. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut. 1990 May;31(5):539–544. doi: 10.1136/gut.31.5.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wellmann W., Fink P. C., Benner F., Schmidt F. W. Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut. 1986 Jul;27(7):814–820. doi: 10.1136/gut.27.7.814. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES